UK Strategy for Industrial Biotechnology Introducing the Industrial Biotechnology Leadership Forum Rebecca Wood Chemistry Innovation KTN 18th September 2013
IB Manufacturing Exhibition 5-16th August 2013
IB Strategy in the UK: Government Support
www.berr.gov.uk/files/file51144.pdf
IB 2025: ‘Maximising UK Opportunities from Industrial Biotechnology in a Low Carbon Economy’ Sales for UK chemistry-using industry using Industrial Biotechnology • Connecting it all together
Driving
Delivering
The estimated global market for IB by 2025: £150 bn - £360 bn
Enabling
• De-risking access to new products and technologies • Accelerating the innovation and knowledge transfer process
• Retaining and developing interdisciplinary talent in science and management • Creating a supportive public and business environment for industrial biotechnology
Download IBIGT report (http://www.berr.gov.uk/files/file51144.pdf) and Government Response (http://www.berr.gov.uk/files/file51891.pdf)
The Chemistry Using Industries
What is industrial biotechnology? IB is defined as “the use of biological substances* for the processing and production of enzymes, chemicals, materials and energy”. * plants, algae, marine life, fungi, micro-organisms White Biotechnology
Green Biotechnology
Blue Biotechnology
Use of micro-organisms, biochemistry, biocatalysts, engineering and fermentation
Discovery & use of novel genes, processes and materials in land plants, agricultural crops and forestry
Discovery & use of novel genes, processes and materials in freshwater and marine organisms
Areas of focus: IB for the design and processing of bio-derived raw materials
IB for onward processing and manufacture of products
Strategic Action Plan
• Connecting it all together
Driving • De-risking access to new products and technologies • Accelerating the innovation and knowledge transfer process
Delivering
Enabling
• Retaining and developing interdisciplinary talent in science and management • Creating a supportive public and business environment for industrial biotechnology
Industrial Biotechnology Leadership Forum – The Members
Driving
•Connecting it all together
Industrial Biotechnology Leadership Forum (IBLF) Structure
STAKEHOLDERS UK Government
Industry
Skills sector bodies
Research councils
Public/private financing
Academic community
EuropaBio
Professional bodies
SusChem
Innovation Norway
UKTI Networking organisations
Regional government and agencies
Driving a bio-based economy in the UK
Events Case studies
www.iblf-uk.com
Social media
National Industrial Biotechnology Facility (NIBF) Development Laboratories • Up to 10 litre working volume Delivering • DSP matched to plant scale up units •Algal processing NIBF 1 •Pilot plant to 750 L •Plug and play processing NIBF 2 •Centre piece is a 10,000 L fermenter • Solvent suite, distillation, wet and dry biomass processing • Focused on biomass to renewable chemicals
• De-risking access to new products and technologies • Accelerating the innovation and knowledge transfer process
Multi-disciplinary team http://www.uk-cpi.com/
Images courtesy of CPI
Academic Centres of Excellence http://www.coebio3.manchester.ac.uk/ Centre of Excellence for Biocatalysis, Biotransformations and Biocatalytic Manufacturing (CoBio3)
http://www.biorenewables.org/ The Biorenewables Development Centre
Images courtesy of the BDC
http://www.beaconwales.org/ The BEACON Biorefining Centre of Excellence
Images courtesy of the MIB (Manchester Institute of Biotechnology) Images courtesy of the BEACON project, Wales
Sector Class Bulk Chemicals Specialty Chemicals Environment
Providers FMCG Pharmaceuticals
Follow up / result of company visit
Company Engagement Programme – The Beginning
Delivering
New IB project initiated
• De-risking access to new products and technologies • Accelerating the innovation and knowledge transfer process
Introduction made Technical input provided
1
Follow up visit
Basic follow up interest
1
1
1
Number of companies per = sector class
1
2
Primary visit only Total companies engaged per awareness level
1
1 Unaware or resistant
1
2
Aware of IB
Open to application
3 Engaged at R&D
2
1
1
4
2
1
1
1
6 Engaged at commercial
Company awareness / activity at the time of visit
7 IB is core business
Company Engagement Programme – January 2013
Sector Class Bulk Chemicals Specialty Chemicals Environment
Providers FMCG Pharmaceuticals
Follow up / result of company visit
New products, processes, services (value generated)
>300 biocatalytic processes, >400 fermentation processes, >1000 products based on renewable raw materials: Value est. Up to£5 bn
1
New IB project initiated
1
Introduction made Technical input provided
1
Follow up visit
1
Basic follow up interest
2
1
Number of companies per = sector class
1
1
1 1
2
1 1 1 2 1 1 4 1 1
2 1 3 1 1 1 3
1
5
2 2 3 6
1 1
1
1 2 1 3
1
4
3 2 1
1
1
1
1 1
1 1 4
2
1
2 5 2 3
1 1
2
2
Primary visit only Total companies engaged per awareness level
3
4
14
Unaware or resistant
Aware of IB
31
23
29
11
Open to application
Engaged at R&D
Engaged at commercial
IB is core business
Company awareness / activity at the time of visit
Project Building and Funding
High value chemicals manufacture through industrial biotechnology
Projects that utilise sustainable bio-based feedstocks and/or biocatalytic processes in the production of higher value chemicals. UK Business Led Business Model
Technical Feasibility
cR&D
£0.25m
£1m
£1.25m
£33k
£150-200k
£500k-1m
75 / 65 %
75 / 65 %
60 / 50%
Single Company
Yes
Yes
No
Collaborative
Yes
Yes
Yes
Project length
< 6 months
6-9months
< 2years
<50%
<50%
<30%
Funding available Project size Funding Allocation
Academic contribution
UK-Norway
• • • • • •
Mid-term review (here) Industrial Biotech Norway (http://www.indbiotech.no/)
MoU signed in Tromsø in April 2010 Building a relationship based on mutual interests Testing possibilities – in Biosciences Vision of collaborative options – in IB and Biorefining Networking events 8 Joint projects
2 year review reported excellent progress
UK Government Investments in Industrial Biotechnology 2009-2013
£12M to establish demonstration facilities – ~£3M pa continued through Catapult funding
Up to £3M pa into Feasibility / CR&D Competitions from TSB – TSB Competitions in UK (incl. partnership with Innovation Norway) – European ERANets
£2.5M into the Biorenewables Development Centre in York £1M into company engagement programme
Enabling a bio-based economy in the UK
Enabling
• Retaining and developing interdisciplinary talent in science and management • Creating a supportive public and business environment for industrial biotechnology
http://www.forumforthefuture.org/sites/defau lt/files/images/Forum/Projects/IndustrialBiotech/Final%20report%20IB%20PDF.pdf
Demonstrating progress 3 years on
Leading IB: A UK Showcase
300 Delegates 45% industry 20% academic 20% IB stakeholders (KTNs, CPI, Cogent....) 15% Funders (public and private)
The bio-based flag
http://www.bbc.co.uk/programmes/p015sc06
http://www.youtube.com/watch?v=SHb8K2Uo 9sU
http://www.bbc.co.uk/news/uk-englandhampshire-22407246
Ministerial Engagement
“£40m investment for IB Catalyst”
RCs and TSB working together: Networks and the IB Catalyst
£15M to fund up to 10 Networks
£25M IB Catalyst Fund
Summary
• >10 delivery partners driving progress towards £12bn opportunity by 2025 with interim milestones • We are on track to deliver the step change in IB for the UK • Looking for even stronger engagement with industry • Working closely with the government on IB • It’s an exciting time to be involved! • • • •
Coherent industry voice Simple and memorable messages Strong leadership Co-operation of multiple stakeholders with different agendas
Thank you
Industrial Biotechnology Special Interest Group
•Together we aim to drive uptake of Industrial Biotechnology through-out the chemistry-using industries Rebecca Wood (
[email protected] +44 7515 334820)
Knowledge Transfer Networks
etc..
Academic & Technology base
